Global Nuclear Medicine Equipment Market Diagnostic Imaging Installations, Nuclear Imaging Equipment Demand, Hospital Procurement, Radiology Infrastructure, Competitive Analysis and Industry Forecast

The Nuclear Medicine Equipment Market size was valued at USD 3.04 Billion in 2025 and the total Nuclear Medicine Equipment revenue is expected to grow at a CAGR of 3.87% from 2026 to 2034, reaching nearly USD 4.28 Billion.

Nuclear medicine equipment utilizes radioactive compounds (also known as nuclear medicine or radiopharmaceuticals) that are either orally or intravenously injected into the body. These devices use radiopharmaceutical radiation to generate pictures of the structures and activities inside the human body. These pictures allow doctors to see into a person's body to diagnose the origin of a disease or injury and deliver an accurate diagnosis.

Nuclear Medicine Equipment Market Analysis from 2025 to 2034

To know about the Research Methodology:- Request Free Sample Report

Rising cancer prevalence, cardiovascular complications, and neurodegenerative problems; growing awareness about the importance of early disease diagnosis; the introduction of advanced nuclear medicine equipment into the market; and the increasing adoption of nuclear medicine appliances by end users are major factors driving the market growth. However, the high cost of nuclear medicine equipment and radiopharmaceutical half-life is estimated to limit the market growth. Also, the increased usage of repurposed diagnostic imaging systems, as well as hospital budget constraints, pose a challenge to the industry growth.

On the other hand, the market is likely to benefit from a solid product pipeline as well as growth and penetration prospects in emerging markets. Some of the leading key players in the global Nuclear Medicine Equipment Market include Philips Healthcare, GE Healthcare, and Cardinal Health Inc. They are continuously strategizing on mergers and acquisitions, strategic alliances, joint ventures, and partnerships for the growth of their market shares.

The Nuclear medicine equipment is designed to solve the diagnostic challenges, a medical image using a small amount of radioactive material to diagnose and control the severity of or for treating numerous disease for instance cancer, heart diseases, neurological disorders, and other abnormalities within the body.

The increasing prevalence of disease among the geriatric population, durable product pipeline, and a growing demand for nuclear medicine procedures in the emerging market are expected to fuel market growth in the forecast years. The high cost of nuclear medicine equipment’s and reduced half-life radiopharmaceuticals hamper the growth of the nuclear medicine equipment market globally. Furthermore, lack of effective data & evidence that supports nuclear medicines improves the patient’s outcome, less reimbursement of medical imaging, and lack of trained physician and radiologist can restraint growth of global nuclear medicine equipment market.

Positron Emission Tomography (PET) dominated the industry in 2025 caused by high-resolution images provided by PET technology that is majorly used in oncology cases to obtain enhanced information about a tumour. Positron Emission Tomography (PET) is sub-segmented into standalone and hybrid. Cost-effectiveness of SPECT will significantly drive segment growth during the forecast period.

Cardiology application segment is expected to witness considerable growth over the coming years owing to increasing awareness about cardiac disorders, increasing the number of people suffering from cardiovascular diseases and rising adoption of a sedentary lifestyle and unhealthy diet escalating disease burden.

Region-wise, the Asia Pacific is anticipated to register the highest CAGR of 10.5% over the forecast period. Demand for nuclear medicine is growing in emerging markets such as China and India due to increasing disposable income, improving healthcare standards, and favourable reforms in foreign policies. China is dominating the Asia Pacific market and is likely to hold on to its leadership position through 2034.

Nuclear Medicine Equipment Market Recent Industry Developments

Nuclear Medicine Equipment Market Scope: Inquire before buying

Nuclear Medicine Equipment Maret, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)

Nuclear Medicine Equipment Maret, Key Players

1. Philips Healthcare
2. GE Healthcare
3. Cardinal Health Inc.
4. Siemens AG
5. Digirad Corporation
6. Mediso Medical Imaging Systems, Ltd.
7. Toshiba Medical Systems Corporation
8. DDD-Diagnostics A/S
9. Neusoft Medical Systems Co. Ltd.
10. Mallinckrodt plc
11. SurgicEye GmbH
12. CMR Naviscan Corporation
13. Canon Medical Systems Corporation
14. Fujifilm Holdings Corporation
15. Bozlu Holding
16. Compañía Mexicana de Radiología CRG
17. Bartec Technologies Ltd.
18. Biodex
19. Cyclopharm
20. Standard Imaging Inc.
21. United Imaging Healthcare Co., Ltd.
22. Curium Pharma
23. Bracco Imaging S.p.A.
24. Novartis AG
25. Lantheus Medical Imaging, Inc.
26. Eckert & Ziegler SE
27. Jubilant Pharmova Ltd.
28. Telix Pharmaceuticals Ltd.
29. Spectrum Dynamics Medical Inc.
30. Mirion Technologies, Inc.

Frequently Asked Questions:

1. Which region has the largest share in Global Nuclear Medicine Equipment Market ?
Ans: Asia Pacific region held the highest share in 2025.

2. What was the Global Nuclear Medicine Equipment Market size in 2025?
Ans: The Global Nuclear Medicine Equipment Market size was USD 3.04 Billion in 2025.

3. What is scope of the Global Nuclear Medicine Equipment Market report?
Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. What is the study period of this Market?
Ans: The Global Market is studied from 2020 to 2034.